Gotowa bibliografia na temat „Non-small cell lung cancer”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Non-small cell lung cancer”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Non-small cell lung cancer"
Cheng, Wenhan, M. D, MS c, Eldon Brown, MS c, Matt Gorman, B. S, Timothy Babushok, M. D i PH D. "Immune Suppression Therapy in Aplastic Anemia Secondary to Atezolizumab in a Patient With Stage IV Non-Small Cell Lung Cancer". International Journal of Medical Reviews and Case Reports 4, Reports in Clinical Medicine and (2020): 1. http://dx.doi.org/10.5455/ijmrcr.atezolizumab-non-small-cell-lung-cancer.
Pełny tekst źródłaHellriegel, H. "ADVANCED NON-SMALL-CELL LUNG CANCER. THE SIGNIFICANCE OF PERSONALIZED THERAPY". Siberian Medical Review, nr 6 (2017): 6–12. http://dx.doi.org/10.20333/2500136-2017-6-12.
Pełny tekst źródłaKlaus-Peter, K. "ADVANCED NON-SMALL-CELL LUNG CANCER. THE SIGNIFICANCE OF PERSONALIZED THERAPY". Siberian Medical Review, nr 6 (2017): 6–12. http://dx.doi.org/10.20333/2500136-2017-6-6-12.
Pełny tekst źródła_, _. "Non–Small Cell Lung Cancer". Journal of the National Comprehensive Cancer Network 6, nr 3 (marzec 2008): 228. http://dx.doi.org/10.6004/jnccn.2008.0021.
Pełny tekst źródłaSkřičková, Jana, Bohdan Kadlec i Ondřej Venclíček. "Non-small cell lung cancer". Vnitřní lékařství 63, nr 11 (1.11.2017): 861–74. http://dx.doi.org/10.36290/vnl.2017.159.
Pełny tekst źródłaEttinger, David S., Wallace Akerley, Gerold Bepler, Matthew G. Blum, Andrew Chang, Richard T. Cheney, Lucian R. Chirieac i in. "Non–Small Cell Lung Cancer". Journal of the National Comprehensive Cancer Network 8, nr 7 (lipiec 2010): 740–801. http://dx.doi.org/10.6004/jnccn.2010.0056.
Pełny tekst źródłaEttinger, David S., Wallace Akerley, Hossein Borghaei, Andrew C. Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D’Amico i in. "Non–Small Cell Lung Cancer". Journal of the National Comprehensive Cancer Network 10, nr 10 (październik 2012): 1236–71. http://dx.doi.org/10.6004/jnccn.2012.0130.
Pełny tekst źródłaFromer, Margot J. "Non-Small-Cell Lung Cancer". Oncology Times 30, nr 4 (luty 2008): 21–25. http://dx.doi.org/10.1097/01.cot.0000313049.69678.f6.
Pełny tekst źródłaHill, A., P. Fisher i D. Yeomanson. "Non-small cell lung cancer". BMJ 345, sep27 1 (27.09.2012): e6443-e6443. http://dx.doi.org/10.1136/bmj.e6443.
Pełny tekst źródłaCox, James D. "Non-small Cell Lung Cancer". Chest 89, nr 4 (kwiecień 1986): 284S—288S. http://dx.doi.org/10.1378/chest.89.4_supplement.284s.
Pełny tekst źródłaRozprawy doktorskie na temat "Non-small cell lung cancer"
Kapeleris, Joanna C. "Circulating tumour cells in non-small cell lung cancer". Thesis, Queensland University of Technology, 2022. https://eprints.qut.edu.au/228607/1/Joanna_Kapeleris_Thesis.pdf.
Pełny tekst źródłaSikkink, Stephen K. "Genetic pathology of non-small cell lung cancer". Thesis, University of Liverpool, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.250405.
Pełny tekst źródłaWong, Wing-sze, i 黃詠詩. "Fusion genes in non-small cell lung cancer". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B43781378.
Pełny tekst źródłaSwinson, Daniel. "Hypoxic markers in non-small cell lung cancer". Thesis, University of Leicester, 2004. http://hdl.handle.net/2381/29476.
Pełny tekst źródłaWong, Wing-sze. "Fusion genes in non-small cell lung cancer". Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B43781378.
Pełny tekst źródłaBrena, Romulo Martin. "Aberrant DNA methylation in human non-small cell lung cancer". Columbus, Ohio : Ohio State University, 2007. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1172083621.
Pełny tekst źródłaBrattström, Daniel. "Angiogenesis related markers in non-small cell lung cancer /". Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl.[distributör], 2003. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3558.
Pełny tekst źródłaXinarianos, George. "Genetic alterations in non-small cell lung carcinomas". Thesis, University of Liverpool, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.343688.
Pełny tekst źródłaBrattström, Daniel. "Angiogenesis Related Markers In Non-Small Cell Lung Cancer". Doctoral thesis, Uppsala University, Oncology, 2003. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3558.
Pełny tekst źródłaThis thesis investigated the predictive and the prognostic powers of angiogenesis related markers in both operable and inoperable non-small cell lung cancer (NSCLC) patients.
In the first and second study, we investigated the serological fractions of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in 2 cohorts of patients with either operable or inoperable NSCLC.
Regarding operable NSCLC, we demonstrated significant correlations between VEGF and tumour volume and overall survival. Regarding bFGF, significant correlations with recurrent disease and survival were demonstrated. VEGF and bFGF correlated to each other and with platelet counts. In multivariate analysis, bFGF proved to be a significantly independent prognostic factor.
Regarding inoperable NSCLC, we demonstrated that patients with elevated bFGF levels before any treatment and during chemotherapy had a significantly poorer survival. During chemotherapy, each rise of one unit of bFGF (ng/L) corresponded to a 4 times increased risk of death. Regarding VEGF, elevated levels after radiotherapy corresponded with better survival. All prognostic information demonstrated in this study concerned patients with a, co-sampled, normal platelet count.
In the third study, three putative markers, HER-2, EGFR and COX-2, suitable for targeted therapies in resected NSCLC were investigated in a panel of 53 tumours and further investigated for a possible correlation with microvessel density. We demonstrated that HER-2 and COX-2 were mainly expressed in adenocarcinomas, whereas EGFR was only expressed in squamous cell carcinomas. COX-2 showed a trend towards a correlation with microvesssel density. The expression profile, HER-2+/EGFR-, was significantly correlated to poorer survival.
In the fourth study, a predictive model for recurrences consisting of p53, CD34 and CD105, and circulating serum fractions of VEGF and bFGF, was investigated. The two endothelial markers correlated with each other. CD105 expression correlated with p53 expression. No other significant correlations between markers could be demonstrated. A significant correlation between p53 overexpression and recurrent disease was demonstrated. The mutational status could not confirm the immunohistochemical correlation between p53 and recurrences.
In conclusion, the present thesis demonstrates that the angiogenic factors VEGF and bFGF analysed in sera have both predictive and prognostic information when measured in operable and inoperable NSCLC. Since HER-2 is overexpressed in NSCLC and linked with prognostic information, this marker might be a suitable target for therapy in NSCLC. Furthermore, in patients with operable NSCLC, p53 expression status was linked with recurrent disease and mean MVD.
Lam, Chi-leung David. "Gene expression profiling in non-small cell lung cancer". Click to view the E-thesis via HKUTO, 2007. http://sunzi.lib.hku.hk/hkuto/record/B38585777.
Pełny tekst źródłaKsiążki na temat "Non-small cell lung cancer"
T, Carr David, i International Cancer Research Data Bank., red. Non-small cell lung cancer. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1988.
Znajdź pełny tekst źródłaRamaswamy, Govindan, red. Locally advanced non-small-cell lung cancer. Manhasset, NY: CMP United Business Media, 2004.
Znajdź pełny tekst źródłaSeeber, Siegfried, red. Small Cell Lung Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-82372-5.
Pełny tekst źródłaRecent advances in locally advanced non-small-cell lung cancer. Manhasset, N.Y: CMPMedica, 2006.
Znajdź pełny tekst źródłaEttinger, David S. The role of chemotherapy in non-small cell lung cancer. Syracuse, NY: Bristol Laboratories Oncology Products, Bristol-Myers Oncology Division, 1986.
Znajdź pełny tekst źródła1935-, Skarin Arthur T., i Alexander Eben, red. Multimodality treatment of lung cancer. New York: M. Dekker, 2000.
Znajdź pełny tekst źródłaJerome, Seidenfeld, Blue Cross and Blue Shield Association. Technology Evaluation Center. i United States. Agency for Healthcare Research and Quality., red. Management of small cell lung cancer. Rockville, MD: Agency for Healthcare Research and Quality, Public Health Service, U.S. Dept. of Health and Human Services, 2006.
Znajdź pełny tekst źródłaBenjamin, Movsas, Langer Corey J i Goldberg Melvyn, red. Controversies in lung cancer: A multidisciplinary approach. New York: M. Dekker, 2001.
Znajdź pełny tekst źródłaauthor, Bujamma D., i M., Naresh Babu (Muppalaneni), author, red. Bioinformatics of non small cell lung cancer and the ras proto-oncogene. Heidelberg: Springer-Verlag, 2015.
Znajdź pełny tekst źródłaCarr, David T. Selected abstracts on small cell lung cancer. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1986.
Znajdź pełny tekst źródłaCzęści książek na temat "Non-small cell lung cancer"
Munden, Reginald F., i Jeremy J. Erasmus. "Thoracic Imaging Techniques for Non-Small Cell and Small Cell Lung Cancer". W Lung Cancer, 35–56. New York, NY: Springer New York, 2003. http://dx.doi.org/10.1007/0-387-22652-4_3.
Pełny tekst źródłaRosell, Rafael, i Delvys Rodriguez-Abreu. "Non-Small-Cell Lung Cancer". W Encyclopedia of Cancer, 1–7. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_4119-3.
Pełny tekst źródłaRosell, Rafael, i Delvys Rodriguez-Abreu. "Non-Small-Cell Lung Cancer". W Encyclopedia of Cancer, 3130–35. Berlin, Heidelberg: Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-46875-3_4119.
Pełny tekst źródłaRosell, Rafael, i Delvys Rodriguez-Abreu. "Non-Small Cell Lung Cancer". W Encyclopedia of Cancer, 2546–51. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_4119.
Pełny tekst źródłaHansen, Heine H. "Non-Small Cell Lung Cancer: Staging and Surgery". W Lung Cancer, 30–41. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-76031-0_18.
Pełny tekst źródłaHansen, Heine H. "Non-Small Cell Lung Cancer: Radiotherapy and Chemotherapy". W Lung Cancer, 42–43. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-76031-0_19.
Pełny tekst źródłaCox, James D., i David J. Stewart. "Chemoradiotherapy for Inoperable Non-small Cell Lung Cancer". W Lung Cancer, 161–75. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-524-8_7.
Pełny tekst źródłaWahl, Michael, Matthew A. Gubens i Sue S. Yom. "Non-small Cell Lung Cancer". W Handbook of Evidence-Based Radiation Oncology, 293–321. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-62642-0_15.
Pełny tekst źródłaNguyen, Quynh-Nhu, Ritsuko Komaki, Daniel R. Gomez i Zhongxing Liao. "Non-small Cell Lung Cancer". W Intensity-Modulated Radiation Therapy, 249–60. Tokyo: Springer Japan, 2015. http://dx.doi.org/10.1007/978-4-431-55486-8_12.
Pełny tekst źródłaJabbari, Siavash, Eric K. Hansen i Daphne A. Haas-Kogan. "Non-small Cell Lung Cancer". W Handbook of Evidence-Based Radiation Oncology, 221–47. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-0-387-92988-0_15.
Pełny tekst źródłaStreszczenia konferencji na temat "Non-small cell lung cancer"
Patel, Sagar S., Ramesh Natarajan i Rebecca L. Heise. "Mechanotransduction of Primary Cilia in Lung Adenocarcinoma". W ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80435.
Pełny tekst źródłaGileva, M. S., E. G. Ufimceva, L. F. Gulyaeva i V. V. Kozlov. "EX VIVO CHARACTERISTICS OF NON-SMALL CELL LUNG CANCER CELLS". W X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023. Novosibirsk State University, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-308.
Pełny tekst źródłaBenammar, Sarra, Fatima Mraiche, Jensa Mariam Joseph i Katerina Gorachinova. "Glucose and Transferrin Liganded PLGA Nanoparticles Internalization in Non-Small Lung Cancer Cells". W Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0227.
Pełny tekst źródłaXing, Fuyong, i Lin Yang. "Robust cell segmentation for non-small cell lung cancer". W 2013 IEEE 10th International Symposium on Biomedical Imaging (ISBI 2013). IEEE, 2013. http://dx.doi.org/10.1109/isbi.2013.6556493.
Pełny tekst źródłaDias, Margarida, Raquel Marçoa, Rita Linhas, Sérgio Campainha, Sara Conde i Ana Barroso. "Non-small cell lung cancer in never-smokers". W ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa2796.
Pełny tekst źródłaNeffati, O., L. Fekih, H. Kammoun, A. Ayari, I. Mejri, H. Smadhi, I. Akrout i in. "Prognostic factors in non-small cell lung cancer". W Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa4294.
Pełny tekst źródłaFu, Pin-Kuei. "Octogenarians With Operable Non-Small Cell Lung Cancer". W American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4407.
Pełny tekst źródłaHamedi, Z., S. Kamboj, S. Kumar, R. A. Jiwani i N. Sharma. "Transformation of Non-Small Cell Lung Cancer (NSCLC) to Small Cell Lung Cancer (SCLC), Mechanism of Treatment Resistance?" W American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4871.
Pełny tekst źródłaPaschoal, Marcos Eduardo M., Teresa C. F. Santos, Nathalie H. S. Canedo, Paulo M. N. Valiante, Heitor S. P. Souza, Mauro S. G. Pavao i Morgana T. L. Castelo Branco. "Heparanase 1 Expression In Non-Small Cell Lung Cancer". W American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6373.
Pełny tekst źródłaCruz, Carla, André Rico, Fani Sousa, Bernardo Teixeira i Daniela Alexandre. "miRNA Detection for non-small cell lung cancer diagnosis". W 7th International Electronic Conference on Medicinal Chemistry. Basel, Switzerland: MDPI, 2021. http://dx.doi.org/10.3390/ecmc2021-11506.
Pełny tekst źródłaRaporty organizacyjne na temat "Non-small cell lung cancer"
Freire, Mariana, Diana Martins, Maria Filomena Botelho i Fernando Mendes. Biomarkers of resistance mechanisms in innovative lung cancer treatments - A systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, wrzesień 2022. http://dx.doi.org/10.37766/inplasy2022.9.0011.
Pełny tekst źródłaWatson, Mark A. Genomic Characterization of Brain Metastasis in Non-Small Cell Lung Cancer Patients. Fort Belvoir, VA: Defense Technical Information Center, styczeń 2014. http://dx.doi.org/10.21236/ada606182.
Pełny tekst źródłaKang, Jing, Jun Zhang, Zongsheng Tian, Ye Xu, Jiangbi Li i Mingxina Li. The efficacy and safety of immune-checkpoint inhibitor plus chemotherapy versus chemotherapy for non-small cell lung cancer: an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, maj 2022. http://dx.doi.org/10.37766/inplasy2022.5.0156.
Pełny tekst źródłaNelkin, Barry D. Role of CDK5 as a Tumor Suppressor Gene in Non-Small Cell Lung Cancer. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2014. http://dx.doi.org/10.21236/ada610950.
Pełny tekst źródłaLi, Yong, Fang Yang i Ya-Yong Huang. Sublobar resection versus ablation for stage I non-small-cell lung cancer: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, styczeń 2021. http://dx.doi.org/10.37766/inplasy2021.1.0075.
Pełny tekst źródłaChen, Zhong-Ke, i Yuan-Shun Xu. I-125 seeds with chemotherapy for progressive non-small-cell lung cancer after first-line treatment. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, październik 2021. http://dx.doi.org/10.37766/inplasy2021.10.0120.
Pełny tekst źródłaPeng, Yinglong, Jinwei Chen, Ziyan Wang, Yihui Cao i Jie Zhao. A Systematic Review and meta-analysis of the efficacy of immunotherapy in the treatment of non-small cell lung cancer. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, czerwiec 2022. http://dx.doi.org/10.37766/inplasy2022.6.0094.
Pełny tekst źródłaPeng, Ciyan, Jing Chen, Sini Li i Jianhe Li. Comparative Efficacy of Chinese Herbal Injections Combined Western medicine for Non-small cell lung cancer: A Bayesian Network Meta-Analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, listopad 2021. http://dx.doi.org/10.37766/inplasy2021.11.0068.
Pełny tekst źródłaTong, Zhangwei, Fei Luo, Xiaojie Yang i Jiangbo Lin. Platinum vs immunotherapy for early resectable non-small cell lung cancer: a systematic review and meta-analysis protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, sierpień 2020. http://dx.doi.org/10.37766/inplasy2020.8.0064.
Pełny tekst źródłaShi, Yucong, Ziqi Chen, Sizhi Wu, Yiwen Lv, Pei Liu, Huachong Xu, Li Deng i Xiaoyin Chen. Comparison of Segmentectomy, Lobectomy and Wedge Resection for Early-stage Non-Small Cell Lung Cancer: A Bayesian analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, sierpień 2020. http://dx.doi.org/10.37766/inplasy2020.8.0090.
Pełny tekst źródła